Double diabetes: possible but unpublished complication of insulin pump therapy

Journal of Diabetes and its Complications

Volumn 22, Issue 2, 2008, Pages 147-149

  Cesur, Mustafa ^a   Cesur, Aylin ^b  

^a GÜVEN HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Continuous subcutaneous insulin infusion; Double diabetes; Insulin pump; Insulin resistance; type 1 diabetes

Indexed keywords

GLUCOSE; HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; ISOPHANE INSULIN; METFORMIN;

ADULT; ARTICLE; BEDTIME DOSAGE; BODY MASS; CASE REPORT; DIABETIC DIET; DIABETIC PATIENT; DOUBLE DIABETES MELLITUS; DRUG DOSE REDUCTION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RESISTANCE; INSULIN TREATMENT; LABORATORY TEST; MALE; METABOLIC SYNDROME X; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT GAIN;

BLOOD CHEMICAL ANALYSIS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN INFUSION SYSTEMS; KINETICS;

EID: 38949143306     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.10.002     Document Type: Article

References (15)

1. Battelino T. Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents. Pediatric Diabetes Suppl 4 (2006) 20-24
2. Hirsch F., Tondeur G., and de Witte C. Hand-Schuller-Christian disease and histiocytosis: X. Apropos of a case with double diabetes. La Semaine Des Hopitaux 48 (1972) 837-844
3. Hurley P.J., Hitchcock G.C., and Wilson J.D. Histiocytosis x and double diabetes. Australasia Annals of Medicine 16 (1967) 250-254
4. Kaufman F. 'Double diabetes' in young people and how to treat it. Diabetes Voice 51 (2006) 19-22
5. Libman I.M., and Becker D.J. Coexistence of type 1 and type 2 diabetes mellitus: "Double" diabetes?. Pediatric Diabetes 4 (2003) 110-113
6. Libman I.M., Pietropaolo M., Arslanian S.A., LaPorte R.E., and Becker D.J. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 26 (2003) 2876-2882
7. Maniatis A.K., Klingensmith G.J., Slover R.H., Mowry C.J., and Chase H.P. Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care. Pediatrics 107 (2001) 351-356
8. Nimri R., Weintrob N., Benzaquen H., Ofan R., Fayman G., and Phillip M. Insulin pump therapy in youth with type 1 diabetes: A retrospective paired study. Pediatrics 117 (2006) 2126-2131
9. Plotnick L.P., Clark L.M., Brancati F.L., and Erlinger T. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 26 (2003) 1142-1146
10. Sibley S.D., Palmer J.P., Hirsch I.B., and Brunzell J.D. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 88 (2003) 3379-3384
11. Teupe B., and Bergis K. Epidemiological evidence for "double diabetes". Lancet 337 (1991) 361-362
12. Tuomi T. Type 1 and type 2 diabetes: What do they have in common?. Diabetes 54 Suppl 2 (2005) 40-45
13. Weinzimer S.A., Sikes K.A., Steffen A.T., and Tamborlane W.V. Insulin pump treatment of childhood type 1 diabetes. Pediatric Clinics of North America 52 (2005) 1677-1688
14. Weissberg-Benchell J., Antisdel-Lomaglio J., and Seshadri R. Insulin pump therapy: A meta-analysis. Diabetes Care 26 (2003) 1079-1087
15. Williams K.V., Erbey J.R., Becker D., Arslanian S., and Orchard T.J. Can clinical factors estimate insulin resistance in type 1 diabetes?. Diabetes 49 (2000) 626-632